RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer

Michelle Shuffett

Michelle L. Shuffett, MD, Chief Medical Officer of RS BioTherapeutics

Format

JPEG

Source

RS BioTherapeutics

Téléchargements